Skip to content

Shortwave Infrared Surgical Imaging Device Study

Tissue Recognition and Depth-Sensing With A.I. Powered Hyperspectral Confocal Shortwave Infrared Imaging

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07744425
Enrollment
50
Registered
2026-08-04
Start date
2026-05-29
Completion date
2026-10-11
Last updated
2026-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholecystitis, Cholecystitis, Chronic, Chronic Calculous Cholecystitis, Multinodular Goiter, Primary Hyperparathyroidism, Sigmoid Colon Diverticulitis, Thyroid and Parathyroid Surgery

Brief summary

The goal of this observational study is to perform an in-human assessment of an investigational shortwave infrared (SWIR) imaging device, aimed to enhance the visualization of critical anatomical structures during surgical procedures in non-vulnerable adults between the ages of 18 and 70+. The main questions are to 1) evaluate the feasibility of utilizing SWIR imaging technology within a clinical environment, 2) ascertain the safety of the device, ensuring that its application does not interfere with or alter the established standard of care, and (3) collect preliminary human data that will inform and support the design of future research investigations. It is not the goal of this study to deviate from the standard of care, nor will it influence the diagnostic or therapeutic decisions made by the clinical team. The central hypothesis of this study is that shortwave infrared (SWIR) imaging will effectively visualize critical anatomical structures, such as nerves, ureters, and bile ducts, in human subjects. This expectation is grounded in favorable preclinical results observed in porcine models and cadaveric studies. Additionally, the investigators aim to demonstrate that the use of SWIR imaging can be accomplished without introducing additional risks to patients or disrupting established surgical workflows. After study subjects have consented, the participating surgeons will use the imaging device to visualize key structure seen during the procedure for no more than 10 minutes per case. The surgeons are also asked to complete a device assessment for each case.

Interventions

DEVICEObservational study of SWIR imaging device in surgery

SWIR surgical imaging device to help surgeons visualize key structures during procedures

Sponsors

Cision Vision, Inc.
Lead SponsorINDUSTRY
Stanford University
CollaboratorOTHER
Johns Hopkins University
CollaboratorOTHER
Endeavor Health
CollaboratorOTHER
University of Notre Dame
CollaboratorOTHER
Massachusetts Institute of Technology
CollaboratorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

Non-vulnerable adults

Exclusion criteria

Vulnerable adults who are not able to provide voluntary, informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Type of structures identifiedMay 29, 2026 to October 11, 2026Anatomic structures seen through the device during surgery

Secondary

MeasureTime frameDescription
Qualitative assessment of device functionality and performance by surgeonsMay 29, 2026 to October 11, 2026These qualitative measures include the ease of use, visualization performance, and the perceived change in their confidence level in their decision-making process.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORLisa M. Knowlton, MD, MPH

Stanford University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 5, 2026